Re­genxbio shares new Duchenne gene ther­a­py da­ta ahead of big read­out next year

Re­genxbio has bio­mark­er da­ta on the first pa­tient younger than 4 years old dosed with its Duchenne mus­cu­lar dy­s­tro­phy gene ther­a­py, show­ing that the pa­tient …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER